The Law Office of Salman M. Al-Sudairi in association with Latham & Watkins has advised Middle East Healthcare Company (MEAHCO) on its $480 million initial public offering and the listing of its shares on the Tadawul, the Saudi Stock Exchange.

MEAHCO is a healthcare service provider in Saudi Arabia that operates four major hospitals Riyadh, Jeddah, Madinah and Aseer. According to Reuters, MEAHCO will offer 30 percent of itself in its initial share sale, equivalent to 27.6 million shares, which will be marketed to institutional investors and then to the public.

A Latham & Watkins team led by Riyadh-based partners Sami Al-Louzi and Salman Al-Sudairi advised MEAHCO on the IPO, the first IPO in Saudi Arabia in 2016.

Related Articles

Latham, Milbank, SyCip act on largest greenfield infra FDI deal in Philippines

by Nimitt Dixit |

Milbank and SyCip Salazar Hernandez & Gatmaitan have acted for global investor Actis on its strategic partnership with the Philippines’ Meralco and its subsidiary, Solar Philippines New Energy Corporation, advised by Latham & Watkins, to invest $600 million in the Terra Solar Project.

SAM, CAM, Latham act on Ather Energy’s upcoming $536 mln IPO

by Nimitt Dixit |

Shardul Amarchand Mangaldas & Co is advising Indian electric two-wheeler maker Ather Energy on its upcoming $536.2 million initial public offering (45 billion rupees), as more emerging companies than ever before turn to India’s red-hot stock market to raise funds.

Trilegal, Latham, Quillon act on Platinum Equity’s India PE debut

by Nimitt Dixit |

Trilegal and Latham & Watkins have advised U.S.-based buyout fund Platinum Equity on its debut private equity deal in India, in the form of the acquisition of a majority stake in Inventia Healthcare, a Mumbai-based pharmaceutical company, at a valuation of $300 million.